Pharmacists Intervention to Improve Hypertension Management in Primary Care
NCT ID: NCT03274531
Last Updated: 2020-04-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
497 participants
INTERVENTIONAL
2017-10-16
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Alberta Clinical Trial in Optimizing Hypertension
NCT00878566
Pharmacy Implementation Trial: Adherence to Antihypertensive Therapy
NCT00460343
Efficacy of Pharmacist Interventions Through the "Medication Therapy Management Pathway in Hypertensive Patients"
NCT06310512
The Pharmacist in the Acute Geriatric Inpatient Treatment Team
NCT03412903
Clinical Pharmacists Role in the Management of Hypertension in Jordan
NCT01079494
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The main inclusion criteria is uncontrolled hypertension, as determined by an automated office blood pressure measurement at a threshold of 135/85 mmHg.
Main exclusion criteria include a first-ever prescription of an antihypertensive agent, resistant hypertension, systolic blood pressure ≥ 180 mmHg and dialysis.
Randomization occurs on the level of pharmacies (cluster randomization).
Patients in the interventional arm are immediately referred to their treating physician for up-titration of antihypertensive therapy. Re-examination of automated automated office blood-pressure occurs in the respective pharmacy, and patients are referred to their treating physician again if required. These measures are accompanied by a structured and educational blood pressure record card.
Patients in the observational arm undergo periodic automated office blood pressure measurements and are referred to their treating physician at the end of the trial in case of persistently uncontrolled blood pressure.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Interventional Arm
Immediate referral of hypertensive patients to the attending physician based on automated office blood pressure measurements
Referral of hypertensive patients to the attending physician
Immediate referral to the treating physician in case of elevated automated office blood pressure measurements
Observational Arm
Repeated automated office blood pressure measurements and referral of hypertensive patients to the attending physician after completion of the trial
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Referral of hypertensive patients to the attending physician
Immediate referral to the treating physician in case of elevated automated office blood pressure measurements
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \> 18 years
* Medically pre-treated arterial hypertension
* Automated office blood pressure ≥ 135 mmHg systolic or ≥ 85 mmHg diastolic
Exclusion Criteria
* First prescription of a new antihypertensive substance or dose adjustment
* Prior therapy with 4 or more different antihypertensive substances
* Systolic blood pressure ≥ 180 mmHg
* Dialysis
* Adherence to the study protocol not to be anticipated
* Inclusion into the study at another study site
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Österreichische Apothekerkammer, Landesgeschäftsstelle Niederösterreich
UNKNOWN
Association for the Promotion of Research in Atherosclerosis, Thrombosis and Vascular Biology
OTHER
Institute for Cardiometabolic Diseases, Karl Landsteiner Society
UNKNOWN
Wilhelminenspital Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Miklos Rohla
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Miklos Rohla, MD
Role: PRINCIPAL_INVESTIGATOR
3rd Medical Department, Cardiology and Intensive Care Medicine, Wilhelminenhospital, Vienna, Austria
Thomas W Weiss, MD, PhD
Role: STUDY_CHAIR
3rd Medical Department, Cardiology and Intensive Care Medicine, Wilhelminenhospital, Vienna, Austria
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Buchen-Apotheke
Alland, , Austria
Apotheke Bad Erlach
Bad Erlach, , Austria
Kur-Apotheke
Bad Vöslau, , Austria
Landschafts-Apotheke
Baden, , Austria
Apotheke Am Goettweiger
Furth, , Austria
Oetscherland-Apotheke
Gaming, , Austria
Apotheke zum heiligen Georg
Gaweinstal, , Austria
Apotheke Gmuend Neustadt
Gmünd, , Austria
Apotheke Zum Auge Gottes
Gmünd, , Austria
Marien-Apotheke
Gramatneusiedl, , Austria
St. Georgs-Apotheke
Himberg, , Austria
Apotheke Zu Maria Trost
Kirchberg am Wagram, , Austria
Stadt-Apotheke
Klosterneuburg, , Austria
Die Blaue Apotheke
Klosterneuburg, , Austria
Kreis-Apotheke Zum schwarzen Adler
Korneuburg, , Austria
Adler-Apotheke
Langenlois, , Austria
Kamptal-Apotheke
Langenlois, , Austria
Kronen-Apotheke
Lilienfeld, , Austria
Apotheke Zur Madonna
Neunkirchen, , Austria
Merkur-Apotheke
Neunkirchen, , Austria
Triesting-Apotheke,
Oberwaltersdorf, , Austria
Apotheke Zum heiligen Georg
Pitten, , Austria
Apotheke Zum St. Nikolaus
Pottendorf, , Austria
Apotheke Zur Mariahilf
Pöggstall, , Austria
Apotheke Purgstall
Purgstall, , Austria
Wallhof-Apotheke
Rannersdorf, , Austria
Apotheke Sued
Sankt Pölten, , Austria
Center Apotheke
Sankt Pölten, , Austria
Hippolyt-Apotheke
Sankt Pölten, , Austria
Rosen-Apotheke
Sankt Pölten, , Austria
Stadt-Apotheke
Schrems, , Austria
Linden-Apotheke
Seitenstetten Markt, , Austria
Johannes-Apotheke
Traisen, , Austria
Apotheke Zur Mutter Gottes
Traismauer, , Austria
Activ Apotheke Tribuswinkel
Tribuswinkel, , Austria
Urania Apotheke
Vienna, , Austria
Siebenbrunnen Apotheke
Vienna, , Austria
Heilfried Apotheke
Vienna, , Austria
Ludwigs Apotheke
Vienna, , Austria
Friedrichs Apotheke
Vienna, , Austria
Linden Apotheke
Vienna, , Austria
Adler Apotheke
Vienna, , Austria
Arkaden Apotheke
Vienna, , Austria
Rosen Apotheke
Vienna, , Austria
Apotheke Neu Kagran
Vienna, , Austria
St. Hubertus Apotheke
Vienna, , Austria
Birken Apotheke
Vienna, , Austria
Apotheke Zur Mariahilf
Wiener Neustadt, , Austria
Bahnhof-Apotheke
Wiener Neustadt, , Austria
Zehnerguertel-Apotheke
Wiener Neustadt, , Austria
Apotheke Wimpassing
Wimpassing, , Austria
Apotheke Zur heiligen Dreifaltigkeit
Wolkersdorf, , Austria
Apotheke Zum schwarzen Adler
Zwettl Stadt, , Austria
Kuenringer Apotheke
Zwettl Stadt, , Austria
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rohla M, Haberfeld H, Tscharre M, Huber K, Weiss TW. Pharmacist interventions to improve blood pressure control in primary care: a cluster randomised trial. Int J Clin Pharm. 2023 Feb;45(1):126-136. doi: 10.1007/s11096-022-01452-1. Epub 2022 Nov 8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APOTHECARE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.